1. Home
  2. Analysis
  3. Cimzia
  4. Alogliptin

Cimzia and Alogliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cimzia (certolizumab pegol) and Alogliptin (alogliptin benzoate). Common drug interactions include asthenia among females and tonsil cancer among males.

The phase IV clinical study analyzes what interactions people have when they take Cimzia and Alogliptin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Cimzia?

Cimzia has active ingredients of certolizumab pegol. It is often used in rheumatoid arthritis. eHealthMe is studying from 106,745 Cimzia users. Check the latest studies of Cimzia.

What is Alogliptin?

Alogliptin has active ingredients of alogliptin benzoate. eHealthMe is studying from 1,943 Alogliptin users. Check the latest studies of Alogliptin.

On Aug, 01, 2026

22 people who take Cimzia and Alogliptin together, and have interactions are studied.

Cimzia and Alogliptin drug interactions.

What are the common drug interactions of Cimzia and Alogliptin, by gender? *:

female:

  1. Asthenia (weakness)
  2. Rash

male:

  1. Tonsil cancer
  2. Appetite disorder (abnormal eating habits)
  3. Diarrhoea
  4. Inflammatory bowel disease

What are the common drug interactions of Cimzia and Alogliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Inflammatory bowel disease

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Tonsil cancer
  2. Appetite disorder (abnormal eating habits)
  3. Diarrhoea

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 19 people, 86.36%
  2. Nausea (feeling of having an urge to vomit): 7 people, 31.82%

* Approximation only. Some reports may have incomplete information.

Do you take Cimzia and Alogliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cimzia and Alogliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cimzia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alogliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cimzia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alogliptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on certolizumab pegol and alogliptin benzoate (the active ingredients of Cimzia and Alogliptin, respectively), and Cimzia and Alogliptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.